Celularity Inc (CELU)
2.76
-0.09
(-3.16%)
USD |
NASDAQ |
Nov 22, 16:00
2.77
+0.01
(+0.36%)
After-Hours: 20:00
Celularity Shareholders Equity (Quarterly): 27.81M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 27.81M |
| March 31, 2024 | 31.24M |
| December 31, 2023 | 40.96M |
| September 30, 2023 | 30.25M |
| June 30, 2023 | 118.50M |
| March 31, 2023 | 155.63M |
| December 31, 2022 | 198.90M |
| Date | Value |
|---|---|
| September 30, 2022 | 164.24M |
| June 30, 2022 | 150.15M |
| March 31, 2022 | 89.90M |
| December 31, 2021 | 99.42M |
| September 30, 2021 | 96.22M |
| June 30, 2021 | 80.96M |
| December 31, 2020 | -531.40M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-531.40M
Minimum
Dec 2020
198.90M
Maximum
Dec 2022
53.77M
Average
93.06M
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly and Co | 14.24B |
| Dentsply Sirona Inc | 2.491B |
| Ligand Pharmaceuticals Inc | 841.18M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 135.49M |
| Total Liabilities (Quarterly) | 107.68M |
| Debt to Equity Ratio | 1.474 |
| Current Ratio | 0.2611 |
| Net Debt Paydown Yield | -1.55% |